Brand-name vs compounded
Embody vs Ro.co: Brand-Name or Compounded? (2026)
Embody or Ro.co? Side-by-side 2026 pricing, medication and service comparison, extended to six and twelve-month totals.
Published · Pricing as published in our provider dataset, synced · Editorial scores 7.6 and 7.5 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
The choice between Embody and Ro.co usually comes down to one difference that neither homepage puts in its headline.
Ro.co dispenses brand-name, FDA-approved finished medication. Embody dispenses compounded medication prepared by a pharmacy rather than manufactured under an approved application. Those are different regulatory categories, and the price difference between them is the whole reason both business models exist.
The comparison below starts from published pricing, converts it into annual cost, and then asks what the more expensive side is delivering for the difference. Every figure traces back to the provider's own published material, and the missing ones stay missing.
The short answer
- Lowest ongoing rate
- Ro.co — $39/mo against $69/mo, though only one of the two publishes enough to total a full year.
- FDA-approved medication
- Ro.co — FDA-approved Wegovy pill (oral GLP-1) and brand-name GLP-1 injectables — a finished product the FDA has reviewed, rather than a compounded preparation.
- Tirzepatide access
- Embody — Tirzepatide at $119/mo; the other side publishes semaglutide only.
- Easiest to pay for
- Embody — Neither publishes financing; both expect the full amount monthly.
Embody vs Ro.co: the specification
The rows below are the ones that differ enough between these two to be worth your attention.
| Embody | Ro.co | |
|---|---|---|
| Advertised price | Semaglutide $69/mo (was $299), tirzepatide $119/mo | Get started online for $39 |
| Rate after promotions | $69/mo | $39/mo |
| Pricing structure | Published rate per medication | Promotional first month, then standard rate |
| Medication | Compounded semaglutide and compounded tirzepatide | FDA-approved Wegovy pill (oral GLP-1) and brand-name GLP-1 injectables |
| Payment options | Card only, no financing published | Card only, no financing published |
| Membership fee | None | None |
| How fast you start | Licensed provider review handled entirely online | Online consultation |
| State coverage | Not published | Not published |
| Patient reviews | 11,250 | 40,215 |
| eRxDoctor score | 7.6/10 | 7.5/10 |
Embody vs Ro.co on total cost, not entry price
Comparing entry prices across these two would be actively misleading, because they escalate differently. The totals below are the honest version, built from the rates each provider publishes.
| Embody | Ro.co | |
|---|---|---|
| First month | $69 | $39 |
| Months 2 onward | $69/mo | Not published |
| 6-month total | $414 | Not computable |
| 12-month total | $828 | Not computable |
| Best published plan | No multi-month discount published | No multi-month discount published |
A like-for-like annual total is not available for Ro.co: ongoing medication pricing varies by plan and is set after the consultation. Treat any comparison that quotes one as an estimate someone else has made for you.
The regulatory difference, in plain terms
On Ro.co's side of the line sits FDA-approved Wegovy pill (oral GLP-1) and brand-name GLP-1 injectables — product manufactured under an approved application, with the batch-to-batch consistency that approval requires.
Embody supplies compounded semaglutide and compounded tirzepatide — compounded medication prepared by a pharmacy rather than manufactured under an approved application. That is what makes $69/mo possible in the first place, and it is also why the oversight is not the same.
This is the decision to make deliberately rather than by price. If the regulatory status of what you are injecting weekly matters to you, that settles it toward Ro.co; if cost is the barrier that has kept you from treating at all, Embody exists for a reason.
Embody in detail
Embody positions itself on the lowest published semaglutide price on this list, with no lock-in. Semaglutide $69/mo (was $299), Tirzepatide $119/mo
You start with licensed provider review handled entirely online; medication arrives via free shipping, 1-2 day delivery after approval. The price behaves as published rate per medication.
On the clinical side, 24/7 support for dosing and side-effect questions, prescribing compounded semaglutide and compounded tirzepatide.
Embody pros
- Licensed provider review handled entirely online
- 24/7 support access for dosing and side-effect questions
- Lowest entry price on this list at $69/month for compounded semaglutide
- Compounded tirzepatide available at $119/month
Embody cons
- Fewer premium features (no integrated coaching or advanced monitoring) than higher-priced platforms
- Compounded medication only, no branded Ozempic, Wegovy, or Zepbound
- $69 semaglutide pricing is a limited-time offer that may increase
The reservation worth holding, particularly next to Ro.co: a limited-time rate with few of the extras that higher-priced platforms bundle.
Ro.co: what you are buying
Get Started Online for Just $39 Against Embody, that puts it in the position of the cheaper option.
The process is online consultation, then home delivery. On money, expect promotional first month, then standard rate — partly published.
Behind the prescription sits established full-service platform with clinician oversight. Available medication: FDA-approved Wegovy pill (oral GLP-1) and brand-name GLP-1 injectables.
Ro.co pros
- Get started online for just $39
- Only mainstream platform offering the FDA-approved Wegovy pill, oral GLP-1, no injections
- Established, full-service platform with strong brand trust
- FDA-approved finished medication, not compounded
Ro.co cons
- Branded and FDA-approved medications cost significantly more than compounded alternatives
- Ongoing medication pricing varies and can be high depending on the plan
- Less price-competitive than compounded-only platforms for budget-driven patients
Read next to Embody, the weak point: an FDA-approved finished medication costs multiples of a compounded vial.
Picking between them
Choose Embody if:
- you want tirzepatide available without changing provider later
- you want the full price in front of you before completing an intake
- the feature you would actually use: the lowest published semaglutide price on this list, with no lock-in
- the level of clinical contact suits you: 24/7 support for dosing and side-effect questions
Choose Ro.co if:
- you want to start on their timeline: online consultation
- delivery works the way you want it to: home delivery
- the monthly rate is the constraint — $39/mo against $69/mo
- you want an FDA-approved finished medication rather than a compounded preparation
The compromises on both sides
On price. Ro.co is the cheaper program at $39/mo against $69/mo. What Ro.co gives up for that is an FDA-approved finished medication costs multiples of a compounded vial; what Embody charges for is the lowest published semaglutide price on this list, with no lock-in.
On commitment. Neither publishes a multi-month discount, so both are month-to-month decisions and neither asks you to prepay for a response you have not had yet. Neither publishes financing options, so plan for the full amount each month.
On clinical contact. 24/7 support for dosing and side-effect questions at Embody; established full-service platform with clinician oversight at Ro.co. Neither is a substitute for in-person care if you have complicating conditions, and both bill you directly rather than your insurer.
On medication. Embody covers compounded semaglutide and compounded tirzepatide; Ro.co covers FDA-approved Wegovy pill (oral GLP-1) and brand-name GLP-1 injectables. Only Embody publishes a tirzepatide route, which matters if semaglutide underdelivers.
The medication, not the platform
Neither Embody nor Ro.co manufactures the molecule it prescribes, and the clinical evidence behind GLP-1 treatment belongs to the drug rather than to any platform selling access to it.
The NIH position is that weight-management medication works alongside changes in eating and activity, not instead of them, per NIH, NIDDK.
The FDA publishes an ongoing record of semaglutide products marketed for diabetes and weight loss, and which of them it has actually approved, per FDA.
Neither platform's marketing changes any of that. It is the same evidence base whichever one takes your card.
Embody vs Ro.co: common questions
What happens when Embody's promotional price ends?
The rate moves to $69/mo, a 0% increase on the advertised entry price. Budget from that number rather than the headline, because it is the one you will pay for eleven of your first twelve months.
Which has more patient reviews, Embody or Ro.co?
Ro.co, with 40,215 against 11,250. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.
How fast can I start with Embody compared with Ro.co?
Embody advertises licensed provider review handled entirely online, with free shipping, 1-2 day delivery after approval. Ro.co advertises online consultation, with home delivery. Both are subject to clinician review and to whether your state and health history clear, so treat the advertised timeline as a best case rather than a commitment.
Do Embody or Ro.co take insurance?
Both run on a direct-pay basis: you pay the platform and it does not bill your insurer. Neither publishes HSA/FSA acceptance, so budget the full amount as out-of-pocket spending.
Are Embody and Ro.co legitimate?
Both are licensed telehealth platforms that route a prescription through a clinician review before anything is dispensed; neither sells medication without one. Embody operates on published rate per medication with pricing published upfront, Ro.co on promotional first month, then standard rate, partly published. The meaningful due diligence is on the medication category and the terms, not on whether the platforms are real.
The verdict
Ro.co is the cheaper of the two to run at $39/mo, but a full-year total is only computable for one side of this comparison, so treat that as a directional finding rather than a settled one.
Embody's case is the lowest published semaglutide price on this list, with no lock-in; its cost: a limited-time rate with few of the extras that higher-priced platforms bundle.
Neither choice is irreversible. Start with the program whose weaknesses you can tolerate, and reassess at month three when you know how you respond to the medication.
Keep comparing
- Yucca Health vs EmbodyBudget vs premium
- TrimRx vs EmbodyBudget vs premium
- Ro.co vs Start WillowBrand-name vs compounded
- Ro.co vs Sprout HealthBrand-name vs compounded
- Hers vs Mochi HealthBrand-name vs compounded
- Hers vs Elevate HealthBrand-name vs compounded
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Embody or Ro.co, and does not sell treatment. Read our ranking methodology.